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A B S T R A C T   
Anorexia nervosa (AN) is difficult to treat with up to half of patients failing to gain weight during treatment. 
Neurobiological factors predicting treatment response in AN are poorly understood. In this longitudinal study, 
we aimed to identify morphological characteristics in the grey matter which predict treatment success in patients 
with AN. Fifty patients with severe AN participated in an eating disorder-specific inpatient treatment. On 
admission, T1-weighted magnetic resonance images were acquired from all patients. Half of the patients suc-
cessfully gained weight, reaching a body-mass index ≥ 17.5 kg/m2. Using voxel-based morphometry, local grey 
matter volumes were compared between the two groups of patients who gained weight and those who did not. 
This approach allowed us to identify anatomical characteristics which predict treatment success in terms of post- 
treatment weight status. Patients who did not reach the weight threshold at discharge had a smaller volume in 
the right cerebellar crus I at the time of admission. In this group, smaller volume was associated with a greater 
alexithymia score. The findings suggest that a trophic state within the cerebellum before treatment might be 
prognostic for treatment success. Consistent with previous reports, this result further substantiates the possible 
role of the cerebellum in the psychopathology of AN.   
1. Introduction 
Treatment of anorexia nervosa (AN) often proves to be difficult, with 
less than half of the patients reaching full remission (Fichter et al., 2017; 
Steinhausen, 2002). Despite the broad availability of multi-modal 
therapies in structured clinical settings, a considerable proportion of 
patients fail to complete treatment programmes and face a chronic 
course of the illness (Fichter et al., 2017; Steinhausen, 2002). The 
persistence of the illness is an unsolved problem in the treatment of AN 
(Compan et al., 2015) and the neurobiological factors predicting treat-
ment response are poorly understood. 
Magnetic resonance imaging (MRI) studies on AN focusing on the 
subgroup of patients with a positive treatment outcome, which is pri-
marily measured by normalization of body weight, report the revers-
ibility of global and local grey matter (GM) reduction (Bernardoni et al., 
2016; Bomba et al., 2015; Kaufmann et al., 2020; Mainz et al., 2012) as a 
correlate of treatment success. Studies investigating predictors of treatment 
success report that lower GM volume of the cerebellum at admission is 
associated with lower body mass index (BMI) at 1–year follow–up in 
adolescent patients with AN (Seitz et al., 2015). Moreover, a region-
–of–interest analysis of the anterior cingulate cortex revealed that higher 
GM volume is associated with more stable remission at 1–year follow-up 
in AN (McCormick et al., 2008). 
Prospective MRI studies investigating the subgroup of patients with a 
poor outcome are lacking. Involving both subgroups and their direct 
comparison has the potential to shed light on the mechanisms under-
lying favourable and unfavourable illness courses in AN. In the present 
study, we thus aimed to identify characteristics in brain anatomy which 
predict the achievement of a body weight above a clinically relevant 
threshold (BMI ≥ 17.5 kg/m2) in response to an eating disorder–specific 
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inpatient treatment. To this end, we assessed the GM volume of patients 
with AN at the time of admission and compared patients who later 
successfully gained weight (“AN weight-restored”, ANwr) to patients 
who did not (“AN non-weight–restored”, ANnr). Thus, the pattern 
resulting from this contrast would be a predictor of treatment success. 
Poorer treatment outcome in AN has been associated with higher 
autistic and obsessive–compulsive traits accompanying the disorder, 
such as a premorbid obsessive-compulsive personality (Wentz et al., 
2009), a comorbid autism spectrum disorder or obsessive–compulsive 
disorder (Råstam et al., 2003). To account for a possible influence of 
these characteristics, psychometric parameters depicting these aspects 
were collected in addition to clinical measures. 
Given of the overall scarce empirical background and the use of 
different samples (adolescents, adults) in the abovementioned MRI 
studies, specific hypotheses regarding brain regions which may be pre-
dictive for treatment success are not obvious. We therefore chose a 
data–driven whole-brain approach to test the hypothesis that smaller 
local GM volume (McCormick et al., 2008; Seitz et al., 2015) is associ-
ated with a lack of treatment success, i.e. poorer weight gain during 
treatment. Additionally, we explored associations with clinical and 
psychometric variables capturing patients’ physical and psychosocial 
state at the time of admission. 
2. Methods 
2.1. Participants and design 
Fifty patients with severe AN (42 restrictive, 8 binge–purge) partic-
ipated in an eating disorder-specific interdisciplinary multimodal inpa-
tient treatment programme to achieve a BMI of at least 17.5 kg/m2 
(diagnostic cut-off level according to ICD-10 (WHO ICD-10, 2016)) and 
were consecutively recruited for the study (mean BMI 14.3 ± 0.97 
kg/m2, min 11.9 kg/m2, max 16.1 kg/m2). The main objectives of the 
treatment were weight normalization (with an average weekly weight 
gain of 700 g), normalization of eating and exercise behaviour, and 
overcoming dysfunctional attitudes towards eating. The duration of 
treatment depends on weight at admission an of weight gain during 
treatment but is generally limited to about 24 weeks. Patients who 
repeatedly did not achieve the required weekly weight gain had to 
discontinue hospitalization. Patients underwent regular somatic exam-
inations. MRI scans were performed at least two weeks after admission 
to rule out acute dehydration as a confounding factor. Treatment success 
was operationalized as weight gain, more specifically as achieving a BMI 
of at least 17.5 kg/m2 in response to the inpatient treatment described 
above. Based on treatment success, two patient groups were differenti-
ated: Patients who achieved a BMI ≥ 17.5 kg/m2 were assigned to the 
“weight–restored” (ANwr) group, while patients who did not (BMI <
17.5 kg/m2) were assigned to the “non-weight-restored” (ANnr) group. 
The difference in weight gain over time between ANwr and ANnr is 
illustrated in Fig. 1. Specific characteristics of ANwr and ANnr are 
presented in Table 1. 
To confirm the diagnosis of severe AN and to identify comorbidities, 
patients were assessed with the Structured Clinical Interview for DSM- 
IV-TR Axis I Disorders (First et al., 2002). Fourteen patients in the 
ANwr group and 11 patients in the ANnr group had a comorbid mental 
disorder: major depression (ANwr: 11; ANnr: 9), major depression and 
anxiety disorder (ANwr: 2; ANnr: 1), obsessive-compulsive disorder 
(ANwr: 1), and major depression and obsessive-compulsive disorder 
(ANnr: 1). Patients who were taking psychotropic medication when they 
entered the study (see Table 1) were instructed to continue the regimen 
as prescribed. Exclusion criteria for the study comprised current or past 
neurological disorders, substance abuse or addiction, and contraindi-
cations to MRI. The study was approved by the local ethics committee 
and the study protocol complied with the latest version of the Declara-
tion of Helsinki. All participants gave written informed consent prior to 
study enrolment. Data of the present sample overlaps in part with 
previous reports of our group (Kaufmann et al., 2020, 2017). 
2.2. Acquisition and analysis of psychometric data 
Validated German versions of the following psychometric tests were 
Fig. 1. BMI development in the two patient subgroups ANwr (weight-restored 
patients with anorexia nervosa) and ANnr (non-weight-restored patients with 
anorexia nervosa) during inpatient treatment. Since patients who do not gain 
weight over a longer period of time despite sufficient portion size and support 
from the treatment team have to leave the treatment programme, treatment 
duration of the ANnr group was shorter compared to the ANwr group (see re-
sults section). The coloured lines are local regression curves per subgroup, with 
the shaded area representing the 95% confidence interval for the curve. The 
dashed–line marks a BMI of 17.5 kg/m2. 
Table 1 
Clinical and psychometric characteristics of the patients.   
ANnr ANwr  
p  mean SD mean SD 
age [yrs] 22.3 4.1 22.0 4.1 0.78 
age of illness onset [yrs] 15.8 2.2 16.4 2.7 0.44 
illness duration [yrs] 6.6 4.2 5.8 4.5 0.52 
education [yrs] a 12.5 2.9 13.3 2.5 0.33 
BMI at admission [kg/m2] 13.5 1.2 13.3 1.2 0.48 
BMI at MRI scan [kg/m2] 14.4 0.9 14.3 1.1 0.67 
BMI at discharge [kg/m2] 15.9 1.4 18.4 0.9 < 0.001 
EDEQ total b 3.3 1.1 3.2 1.3 0.76 
EDEQ eating constraint b 3.1 1.2 3.2 1.6 0.89 
EDEQ restraint b 3.3 1.3 3.3 1.8 0.89 
EDEQ shape concern b 3.7 1.2 3.5 1.3 0.60 
EDEQ weight concern b 3.2 1.6 2.9 1.2 0.41 
BDI (depressiveness) b 24.8 12.0 23.4 9.8 0.67 
STAI trait (anxiety) b 57.3 11.3 55.9 12.3 0.71 
OCI (obsessive-compulsive traits) b 38.4 7.8 34.6 10.0 0.16 
TAS (alexithymia) c 53.6 7.1 52.0 5.5 0.44 
WMT (non-verbal intelligence) d 115.0 20.0 122.0 17.8 0.21 
WST (verbal intelligence) d 101.7 10.1 106.0 8.8 0.13  
ANnr ANwr  
p  n n 
AN restrictive/binge-purge 21/4 21/4 1.0 
unmedicated/medicated 16/9 13/12 0.57 
Note: Psychometric data was collected at the time of admission. ANwr: Patient 
with anorexia nervosa, weight-restored; ANnr: patient with anorexia nervosa, 
non-weight-restored; SD: standard deviation; BMI: body-mass index; EDEQ: 
Eating Disorders Examination Questionnaire; BDI: Beck Depression Inventory, 
STAI: Spielberger State-Trait Anxiety Inventory; OCI: Obsessive-Compulsive 
Inventory; TAS: Toronto Alexithymia Scale; WMT: Viennese Matrices Test for 
non-verbal intelligence; WST: Viennese Vocabulary Test for verbal intelligence. 
Medication comprised antidepressants, atypical antipsychotics, or anxiolytics. 
Missing data: 
a ANwr: 1. 
b ANnr: 6. 
c ANnr: 6, ANwr: 1. 
d ANnr: 2 (and for WST, ANwr: 1). 
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used in this study: Viennese Matrices Test for non–verbal intelligence 
(Formann and Piswanger, 1979), Viennese Vocabulary Test for verbal 
intelligence (Schmidt and Metzler, 1992), Spielberger State–Trait Anx-
iety Inventory for trait anxiety (Laux et al., 1981), Beck Depression In-
ventory (Hautzinger et al., 1994) for depression severity, 
Obsessive-Compulsive Inventory (short version) for 
obsessive-compulsive traits (Foa et al., 2002), 20–item Toronto Alex-
ithymia Scale (Bagby et al., 1994) for alexithymia traits and Eating 
Disorder Examination Questionnaire (Hilbert et al., 2004) for eating 
disorder cognitions. To assess group differences in the psychometric 
data, Welch’s t-tests for two samples were applied using R version 4.0.2 
(R Core Team, 2020). 
2.3. Acquisition and analysis of magnetic resonance imaging data 
Brain images were acquired with a 3.0 Tesla whole-body MRI system 
(Ingenia, Philips, Best, The Netherlands), equipped with a 32-channel 
head coil. Whole–brain 3D T1–weighted structural images were ac-
quired using a 3D Turbo-Field-Echo sequence (echo time = 3.8 ms, 
repetition time = 8.3 ms, inversion time = 1020 ms, shot interval =
2010 ms, field of view = 240 × 240 mm2, acquisition matrix = 240 ×
240, 160 slices, isotropic voxel size = 1 mm3, flip angle = 8◦, TFE factor 
= 240, duration = 4.5 min). For all subjects, T1-weighted (and addi-
tional diagnostic T2-weighted) images were inspected for relevant brain 
pathology or anomalies by a trained neuroradiologist. 
Differences in local GM volume between ANwr and ANnr were 
evaluated using whole-brain voxel-based morphometry (VBM) (Ash-
burner and Friston, 2000; Good et al., 2001). T1-weighted MRI scans 
were pre-processed and analysed with the FSL–VBM tool (Douaud et al., 
2007) (fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLVBM), an optimized VBM pro-
tocol (Good et al., 2001) implemented in FSL (Smith et al., 2004). First, 
structural images were brain-extracted and GM-segmented before being 
registered to MNI152 space using non-linear registration (Andersson 
et al., 2007). The resulting images were averaged and flipped along the 
x-axis to create a left-right symmetric, study-specific GM template. 
Second, all native GM images were non-linearly registered to the 
study-specific template and modulated to correct local contraction or 
expansion of voxels due to the non–linear component of the spatial 
transformation (Jacobian modulation). This modulation preserves ab-
solute volumes such that the inclusion of total intracranial volume in 
subsequent statistical models as a covariate becomes obsolete (Ash-
burner and Friston, 2000; Good et al., 2001; Malone et al., 2015). The 
modulated GM maps were then smoothed with an isotropic Gaussian 
kernel with a sigma of 3, corresponding to a full width at half maximum 
(FWHM) Gaussian kernel of about 7 mm. Finally, voxel-wise general 
linear models were calculated using permutation-based non-parametric 
testing with 5000 permutations of the group label (Smith and Nichols, 
2009). The significance threshold was set at α = 0.05, correcting for 
multiple comparisons with the threshold free cluster enhancement 
method using family-wise error correction. 
After group comparison, individual cluster means were extracted to 
(i) visualize the data and check for anomalies or outliers and to (ii) 
systematically examine group-specific Pearson correlations with the 
clinical (age of illness onset, duration of illness, BMI at MRI scan) and 
psychometric variables (eating disorder symptom severity, depression, 
obsessive-compulsive trait, anxiety trait, alexithymia trait). As we con-
ducted eight correlation analyses, we adjusted the significance level to α 
= 0.006 using the Bonferroni correction. 
Global brain tissue volumes for GM and white matter (WM) and 
ventricular cerebrospinal fluid (CSF), normalised for patients head size, 
were calculated with SIENAX version 2.6 (Smith et al., 2002), part of FSL 
(Smith et al., 2004). Brain extraction was run with optimised parameters 
for robust brain centre estimation (using the option ‘-R’). Group com-
parisons were calculated using Welch’s t–tests for two samples in R 
version 4.0.2 (R Core Team, 2020). 
3. Results 
For ANwr, the mean duration of treatment was 24 ± 4 weeks (mean 
± standard deviation), for ANnr, the mean time between admission and 
discharge was 14 ± 7 weeks. ANwr and ANnr did not differ in any of the 
clinical and psychometric variables at the time of admission (Table 1). 
Moreover, the proportion of patients who had a comorbid diagnosis of 
depression did not differ between groups (X2(1) = 0.322, p = 0.57). 
VBM yielded a cluster with smaller GM volume in ANnr compared to 
ANwr. This cluster was located in the crus I of the right pontocerebellum 
(cluster size: 311 voxels, p = 0.009, MNI coordinates: x/y/z : 32 / −88 / 
−32, see Fig. 2). There were no clusters with increased GM volume in 
ANnr compared to ANwr. Further, there was no evidence for differing 
global GM, WM or ventricular CSF volumes between ANnr and ANwr 
(Table 2). Exploratory correlation analyses showed that in the ANnr 
group, the mean GM volume of the identified cluster negatively corre-
lated with alexithymia score (r = −0.58, p = 0.009). However, this 
correlational result was not significant according to an adjusted signif-
icance level of α = 0.006. Further, there were no significant or trend 
correlations with clinical (age of illness onset, duration of illness, BMI at 
MRI scan) or with other psychometric variables (eating disorder symp-
tom severity, depression, obsessive-compulsive trait, anxiety trait) in 
either group (Table 3). 
4. Discussion 
In the present study, we aimed to identify GM characteristics pre-
dictive of treatment success (i.e., post–treatment weight status) in pa-
tients with AN. Using VBM in a whole–brain approach, we found a 
smaller volume in the crus I of the right cerebellum in ANnr compared to 
ANwr. Crucially, the smaller volume of the identified cluster was 
measured after initial weight restoration to exclude dehydration effects 
and was independent of illness duration or patients BMI at MRI scan. 
This is further evidence for the hypothesis that a lack of treatment suc-
cess is associated with smaller GM volume. Our results are consistent 
with a previous report of an association between smaller cerebellar 
Fig. 2. Grey matter volume differences between non–weight–restored anorexia 
nervosa (ANnr) patients and weight–restored (ANwr) patients, detected using 
voxel–based morphometry. A þ B: Cluster of significantly smaller grey matter 
volume in ANnr patients compared to ANwr patients in the right crus I (cluster 
size: 311 voxels, p = 0.009, MNI coordinates: x/y/z: 32 / −88 / −32). C: 
Boxplots comparing the cluster-specific volume (cm3) of the two groups. A =
anterior, P = posterior, S = superior, L = left, R = right. 
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volume and weight status at 1–year follow–up in adolescent patients 
with AN (Seitz et al., 2015). In addition, smaller cerebellar volume has 
been associated with a chronic trajectory of AN (Boghi et al., 2011). 
Together, these results suggest that a neural mechanism within the 
cerebellum might play an important role in treatment adherence in AN. 
The cerebellar crus I, especially the right one, is known as the cere-
bellar association zone: In contrast to the sensorimotor functions rep-
resented by adjacent parts of the cerebellum, it is connected to the 
prefrontal cerebral cortex, to the fronto–parietal control network and to 
the default-mode network (Buckner, 2013). As such, it is involved in a 
great variety of social, executive, cognitive and self-referential pro-
cesses, which are targeted in the multi-modal treatment of AN, e.g., 
dealing with the intense fear of gaining weight or detaching from ru-
minations about what (not) to eat. 
A core psychopathological feature of AN is that thought and 
behaviour have a rigid, repetitive and compulsive character (Friederich 
and Herzog, 2011), similar to autism spectrum (Kerr-Gaffney et al., 
2021) and obsessive-compulsive disorders (Bastiani et al., 1996). 
Studies investigating patients with these disorders have previously re-
ported volume reductions in crus I (D’Mello et al., 2015; Nar-
ayanaswamy et al., 2016), the same region as in the present study. Both 
autistic behaviour and obsessive-compulsive behaviour have a prog-
nostic value for therapeutic outcome in AN, whether at a subclinical 
level as a personality trait (Wentz et al., 2009) or as a clinical comor-
bidity (Råstam et al., 2003). Taken together, one possible interpretation 
is that the failure of ANnr patients to gain weight may stem from a 
neurobiological predisposition linked to rigid and compulsive psycho-
logical traits. That is, a smaller volume of the right crus I of the cere-
bellum could reflect a deficient integration of cognitive, emotional and 
behavioural input (“the new”) from treatment, such that patients 
continue to adhere rigidly and inflexibly to “the old”. This interpretation 
would align with an animal study in which disruption of the right crus I 
function led to repetitive and inflexible behaviour (Stoodley et al., 
2017). However, for obsessive-compulsive traits (measured with the 
obsessive-compulsive inventory), we did not observe a significant dif-
ference between ANwr and ANnr or a correlation with cluster volume in 
either group. Conversely, for alexithymia (measured with the Toronto 
Alexithymia Scale), which is considered to represent a psychological 
link between autistic traits and AN (Vuillier et al., 2020), there was 
marginal evidence for a correlation with cluster volume in ANnr. That is, 
the lower the volume, the higher the alexithymia of these patients. The 
link between autism-related traits and treatment outcome in AN is also 
supported by reports linking lower brain activation during a 
theory-of-mind task to poorer treatment outcome in patients with acute 
AN (Schulte-Rüther et al., 2012). However, since the correlation be-
tween cluster volume and alexithymia in ANnr was not significant 
considering the adjusted significance level, this exploratory result 
should be considered with caution. Given (i) the existing reports of high 
alexithymia as a predictor of a poorer treatment outcome (Speranza 
et al., 2007) and (ii) the great topical interest of researchers in the 
connection between alexithymia and therapeutic outcome in AN (Gra-
maglia et al., 2020), we consider the present result to be worth 
mentioning. 
Another interpretation is that the smaller crus I volume in ANnr re-
flects an unspecific, biological predisposition within this patient sub-
group. Indeed, the cerebellum has been argued to be susceptible to 
persistent deficits (Seitz et al., 2016) and less “recoverable over time” in 
the context of early life stress (Adamaszek et al., 2017) and prenatal 
stress (Koning et al., 2017). Against this background, ANnr patients’ 
cerebellar deficit would represent an unspecific biological vulnerability 
that expresses as a low susceptibility to treatment and a lack of success in 
weight gain in AN. The lack of a group difference of illness duration and 
the lack of a correlation of cerebellar crus volume with illness duration 
supports the interpretation of an unspecific vulnerability. 
This study is, to our knowledge, the first to identify potential 
neurobiological predictors of treatment success in adults with AN. 
Several limitations should be considered when interpreting our results. 
First, the time frame of the present study focused on the current treat-
ment episode, independent of previous therapies or long-term patient 
outcomes. It is possible that patients in the ANnr group gained weight as 
they progressed. However, clinical experience shows that this is rarely 
possible without additional treatment. Second, the sample size is mod-
erate. Inferences regarding long-term outcomes thus require replication 
in larger samples with a longer observation period. Furthermore, a more 
detailed analysis of the influence of individual pharmacological treat-
ments is not viable with the present sample and should be investigated in 
future studies. Third, the nature of our analysis approach does not allow 
for prediction on an individual level, but rather represents a first step for 
future efforts in this direction. 
To conclude, our results suggest that distinct structural deficits in the 
cerebellum before treatment are predictive of a poorer weight status 
after treatment in patients with AN. This finding provides new insights 
into the role of the cerebellum in AN. 
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